# Angiodynamics Inc: Form 10-K/A for the period ended May 31, 2026

- Company: [Angiodynamics Inc](/companies/ango.md) (CIK 1275187)
- Form: 10-K/A
- Filed: 2026-09-29
- Accepted by EDGAR: Sep 29, 2026, 16:01 ET
- Period: 2026-05-31
- Accession: 0001140361-26-037995
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1275187/000114036126037995/ef20082884_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1275187/000114036126037995/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2026-05-31.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Net income | 12 months, 2025-06-01 to 2026-05-31 | −$36.7m | us-gaap:NetIncomeLoss |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/1275187/000114036126037995/ef20082884_10ka.htm

Filed Sep 29, 2026.
Source: SEC EDGAR, the filing index for accession 0001140361-26-037995. Last ingested by Listed: Nov 4, 2026, 20:24 ET. No prices; not investment advice.